Results 11 to 20 of about 422,109 (155)
【目的】探讨纯母乳喂养新生儿血糖变化及低血糖的影响因素。【方法】在出生后1、4、8、12 、24、48 、72 h 对纯母 乳喂养的新生儿306 例进行血糖系列监测。【结果】新生儿出生后1 h 的平均血糖浓度较低为(2.8±0.95)mmol/ L, 4 h 后升 高并逐渐稳定为(3.22±1.03)mmol/ L;有糖代谢异常母亲的新生儿、巨大儿、低体重儿, 其出生3 天内低血糖的发生率分别 为22.4 %(11/49)、36.9%(31/ 84)、29.6 %(8/27 ...
谢红宁 +4 more
doaj +1 more source
目的肝糖原贮积病(GSD)患者有反复的低血糖发作。本研究的目的是调查分析儿童肝糖原贮积病(GSD)日常血糖及生化指标,为预防低血糖发作和临床管理提供数据支持。方法横断面现场调查研究,收集2024年7月14日在广东省人民医院儿科进行医患交流义诊活动的肝GSD患者及家长的临床资料,现场采集患者及家庭对照者的外周血,检测和分析两组间血糖及生化指标的差异。结果44例肝GSD患者中男34例,女10例。亚型包括GSD Ib型14例、Ia型15例,Ⅲ型2例,Ⅵ型7例,Ⅸ型6例。年龄为7.60(5.08~11.98)岁,
马妮 +5 more
doaj +2 more sources
目的】 探讨血管紧张素II 1型受体拮抗剂替米沙坦对自发性高血压大鼠(SHR)糖代谢及血清脂联素的影响。 【方法】 实验分为4组: 对照组(WKY,n = 10);高血压组(SHR,n = 10);替米沙坦组(替米沙坦,50 mg·kg-1·d-1,n = 10),氨氯地平组(氨氯地平 10 mg·kg-1·d-1,n = 10),另外两组给予安慰剂,均为灌胃法给药,12周后处死大鼠,用生化方法测定糖代谢指标,ELISA方法测定血清脂联素含量。【结果】 四组大鼠空腹血糖之间没有明显差异(P > 0.05)
doaj +1 more source
Highlights The Blood Pressure Control Target in Diabetes (BPROAD) study is a multicenter, randomized controlled trial conducted in mainland China to test the hypothesis of whether intensive blood pressure (BP) management (systolic BP <120 mm Hg) has additional benefits over standard BP management (systolic BP <140 mm Hg) over a follow‐up period of up ...
The BPROAD Study Group +18 more
wiley +1 more source
Highlights The optimal blood pressure (BP) target in patients with type 2 diabetes mellitus (T2DM) for the management of cognitive decline remains unknown. The Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study was designed to determine whether intensive BP treatment (systolic BP <120 mm Hg) reduces risk of dementia and mild cognitive ...
The BPROAD Study Group +18 more
wiley +1 more source
Highlights Lipid profiles of small extracellular vesicles (sEVs) in patients with diabetes or diabetic cardiovascular disease are rarely reported. n‐3 docosahexaenoic acid (DHA)‐enriched triacylglycerol (TG) was found to decrease in sEVs from serum of patients with diabetic cardiovascular disease (DM‐CAD).
Wei Ding +3 more
wiley +1 more source
Highlights Glucagon receptor (GCGR) monoclonal antibody (mAb) improves cardiac function and attenuates microvascular damage in db/db mice. GCGR mAb ameliorates the oxidative stress of cardiac microvascular endothelial cells in diabetic mice. GCGR mAb counteracts the diabetes‐induced upregulation of carnitine palmitoyltransferase 1B, optic atrophy type ...
Peng Wang +6 more
wiley +1 more source
Highlights Among 301 studies, diabetes mellitus was the most studied cardiometabolic risk factor. In the network meta‐analysis, cerebrovascular disease had the highest impact (relative risk [RR] 1.69; 95% CI, 1.65–1.73) on COVID‐19 outcomes compared to other cardiometabolic risk factors.
Alina Binbin Li +9 more
wiley +1 more source
Highlights Preclinical data showed that dipeptidyl peptidase‐4 inhibitors (DPP‐4is) may prevent insulin‐induced atherosclerosis. In patients treated with insulin for type 2 diabetes who underwent ≥2 serial coronary computed tomography angiographies(CCTA), a new obstructive coronary artery disease (OCAD) was less developed on the follow‐up CCTA in those
Young Choi +4 more
wiley +1 more source
Highlights Both interleukin‐10 levels and exosomal miR‐let‐7c‐5p levels are correlated with cognitive function in patients with type 2 diabetes mellitus. There is a negative association between interleukin‐10 levels and exosomal miR‐let‐7c‐5p levels in the plasma of patients with type 2 diabetes mellitus. Abstract Background Interleukin (IL)‐10 plays a
Hui Zhang +9 more
wiley +1 more source

